PISCIANZ, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 5.713
EU - Europa 3.907
AS - Asia 2.164
SA - Sud America 244
AF - Africa 69
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.112
Nazione #
US - Stati Uniti d'America 5.634
PL - Polonia 2.105
SG - Singapore 790
CN - Cina 499
IT - Italia 408
SE - Svezia 368
VN - Vietnam 261
HK - Hong Kong 247
BR - Brasile 181
UA - Ucraina 164
FR - Francia 159
DE - Germania 152
GB - Regno Unito 98
FI - Finlandia 83
RU - Federazione Russa 83
TR - Turchia 83
KR - Corea 69
IE - Irlanda 68
NL - Olanda 60
BG - Bulgaria 57
IN - India 54
CA - Canada 32
MX - Messico 26
AR - Argentina 24
BD - Bangladesh 22
BE - Belgio 21
JP - Giappone 21
ES - Italia 19
SN - Senegal 18
MA - Marocco 15
AT - Austria 14
ZA - Sudafrica 11
IQ - Iraq 10
SA - Arabia Saudita 10
VE - Venezuela 10
PH - Filippine 9
PK - Pakistan 9
AU - Australia 8
DK - Danimarca 8
ID - Indonesia 8
IL - Israele 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
TH - Thailandia 7
CL - Cile 6
CO - Colombia 6
MY - Malesia 6
CH - Svizzera 5
EC - Ecuador 5
EG - Egitto 5
IR - Iran 5
JO - Giordania 5
LT - Lituania 5
PT - Portogallo 5
RO - Romania 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EU - Europa 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
DZ - Algeria 3
HN - Honduras 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PR - Porto Rico 3
UY - Uruguay 3
AO - Angola 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
EE - Estonia 1
FJ - Figi 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 12.106
Città #
Warsaw 2.055
Fairfield 587
Ashburn 554
Woodbridge 534
Singapore 488
Houston 435
Chandler 323
Ann Arbor 309
Seattle 264
Wilmington 259
San Jose 244
Hong Kong 241
Jacksonville 167
Cambridge 159
Beijing 128
Chicago 122
Los Angeles 117
Trieste 114
Princeton 94
Boardman 92
Ho Chi Minh City 71
Columbus 64
Seoul 61
Izmir 57
Sofia 57
Dublin 54
Dallas 50
Dearborn 50
Hanoi 49
Lauterbourg 45
Santa Clara 42
New York 41
Zgierz 41
Frankfurt am Main 39
Moscow 38
Salt Lake City 38
Dong Ket 36
Council Bluffs 34
Buffalo 32
Hefei 32
Munich 30
Milan 26
Helsinki 25
San Diego 25
The Dalles 25
Düsseldorf 23
Elk Grove Village 23
Orem 21
Rome 21
São Paulo 21
Tampa 21
London 20
Brussels 19
Dakar 18
Jinan 18
Phoenix 18
Nanjing 16
Brooklyn 14
Da Nang 14
Des Moines 13
Falls Church 13
Shannon 13
Casablanca 12
Guangzhou 12
Haiphong 12
Kunming 12
Montreal 12
Stockholm 12
Tokyo 12
Portsmouth 11
Shanghai 11
Atlanta 10
Chennai 10
Denver 10
Mumbai 10
Nuremberg 10
Poplar 10
Redondo Beach 10
Redwood City 10
Turku 10
Amsterdam 9
Bremen 9
Kocaeli 9
San Francisco 9
Washington 9
Hebei 8
Johannesburg 8
Manchester 8
Ottawa 8
Tianjin 8
Vienna 8
Bexley 7
Boston 7
Grafing 7
Hangzhou 7
Lancaster 7
Mexico City 7
Sterling 7
Sydney 7
Ankara 6
Totale 9.005
Nome #
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 627
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 473
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 439
Neuronal Dysfunction Associated with Cholesterol Deregulation. 429
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 410
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 405
Type i interferon-mediated autoinflammation due to DNase II deficiency 390
Altered pattern of tumor necrosis factor-Alpha production in peripheral blood monocytes from Crohn's disease basic study 389
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 386
Knockdown of MVK does not lead to changes in NALP3 expression or activation 361
Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs 350
An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers 304
Clinical Genetic Testing of Periodic Fever Syndromes 299
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 283
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 281
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 280
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 276
In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords 270
Piccolipiù, a multicenter birth cohort in Italy: protocol of the study. 268
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 264
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 260
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 259
The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation 242
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 242
Impact of methylmercury and other heavy metals exposure on neurocognitive function in children of 7 years old: study protocol of the follow-up 238
Regulatory T-Cell Function Is Impaired in Celiac Disease. 231
Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. 231
Putative modifier genes in mevalonate kinase deficiency 212
Selective resistance to different glucocorticoids in severe autoimmune disorders 202
From Bone Marrow Transplantation to Cellular Therapies: Possible Therapeutic Strategies in Managing Autoimmune Disorders 193
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 185
Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies 185
Corrigendum to “Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency” [Immunol. Lett. 214 (2019) 52–54](S0165247819302342)(10.1016/j.imlet.2019.08.003) 181
Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature 180
Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic 179
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 174
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 168
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 163
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 160
Hydroxychloroquine modulates immunological pathways activated by RNA:DNA hybrids in Aicardi–Goutières syndrome patients carrying RNASEH2 mutations 156
Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies 152
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 151
New Mechanisms in Autoinflammatory Diseases 146
Priming of the cgas‐sting‐tbk1 pathway enhances lps‐induced release of type i interferons 143
Familial hypogammaglobulinemia with high RTE and naïve T lymphocytes 128
The effect of clodronate on a mevalonate kinase deficiency cellular model. 117
null 109
Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency 109
null 108
Totale 12.388
Categoria #
all - tutte 29.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021279 0 0 0 0 0 0 0 0 0 154 40 85
2021/2022714 37 30 71 60 48 54 35 27 79 64 43 166
2022/20231.001 114 158 71 133 89 141 6 95 123 16 39 16
2023/2024596 24 46 47 29 55 59 122 106 5 9 43 51
2024/20251.307 22 51 106 136 124 90 96 86 172 171 130 123
2025/20262.990 617 105 198 197 273 240 508 98 376 378 0 0
Totale 12.388